Fig. 6

Antigen binding properties determined by ELISA. (a-b) Binding of titrated amounts of faricimab to (a) Ang-2 and (b) VEGF. The binding curves in (a-b) represent the average of individual binding curves from each sample group (averaged from n = 9 per curve). We retrieved single values from the exponential phase of the binding curves for statistical analyses, at (c) [faricimab] = 296.04 ng/mL for Ang-2 and (d) [faricimab] = 74.04 ng/mL for VEGF. ns = non-significant